Current share price of US$483 suggests Vertex Pharmaceuticals is potentially 44% undervalued Analyst price target for VRTX is US$509 which is 40% below our fair value estimate ...
Welcome to Money Diaries where we are tackling the ever-present taboo that is money. We’re asking real people how they spend their hard-earned money during a seven-day period — and we’re tracking ...
For over three decades, the SM Foundation has been empowering countless aspiring youth through its scholarship program. What began as a vision of SM Group founder Henry Sy, Sr. to uplift communities ...